|Bid price||1,333.00||Open price||1,317.00|
|Ask price||1,335.00||Prev close||1,335.00|
Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.
Register now for FREE Dechra Pharmaceuticals share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB0009633180|
|Activites||Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.||Index||FTSE 250|
|Latest Share Price (p)||1,335.00||Net Gearing (%)||17.70|
|Market Capitalisation (£m)||1,231.13||Gross Gearing (%)||33.42|
|Shares in issue (m)||92.71||Debt Ratio||21.58|
|P/E Ratio||59.98||Debt-to-Equity Ratio||0.55|
|Total dividends per share (p)||16.94||Assets / Equity Ratio||1.50|
|Dividend Yield (%)||1.31||Price to book value||6.33|
|Dividend cover (x)||1.25||ROCE (%)||10.41|
|Earning per share (p)||22.14||EPS Growth (%)||-67.23|
|52 week high / low||1,423.00 / 811.00||DPS Growth (%)||10.00|
|Dec.Date||Type||Director||Pos||No. of Shares|
Dechra Pharmaceuticals has appointed Richard Cotton as chief financial officer following the resignation of Anne-Francoise Nesmes which was announced in February. Cotton will join the company once he has served the notice period in his current role as CFO of Consort Medical, which is expected...
/* */ RNS Number : 3280H Dechra Pharmaceuticals PLC 17 August 2016 17 August 2016 Dechra ® Pharmaceuticals PLC (Dechra, Company or the Group) Board Changes Appointment of Chief Financial Officer Further to the...
/* */ RNS Number : 2976G Dechra Pharmaceuticals PLC 04 August 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity...
Register now for FREE Dechra Pharmaceuticals company news
A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...
Register now for FREE Dechra Pharmaceuticals share price discussions